<% var healthname = "healthcare professional"; var healthnamecap = "Healthcare Professional"; var docname = "healthcare professional"; var healthname_begincaps = "Healthcare professional"; %>

Guide to ABILIFY.com

For people with schizophrenia:

• ABILIFY.com Home Page

• ABILIFY and Schizophrenia

• Effective Symptom Improvement

• Once-a-Day Dosing

• IMPORTANT SAFETY INFORMATION

• FULL PRODUCT INFORMATION including Boxed WARNING

• Side Effects

• The Brain, Schizophrenia, and ABILIFY — Video

• The Brain, Schizophrenia, and ABILIFY — Text

• Personal Stories

• Getting the Most from Treatment

• Take Medicine as Prescribed

• Make Healthy Changes to Your Lifestyle

• Stay Connected with Family and Friends

• Set Goals for Yourself

• Working with a Treatment Team

• Talking to Your Healthcare Professional

• Medicine Side Effect Checklist

• Questions to Ask Your Healthcare Professional About ABILIFY

For caregivers, family, and friends of people with schizophrenia:

• Caregiver's Roadmap

• What You Need to Know About Schizophrenia

• Treatment

• Learn About the Treatment Team

• Find Your Role on the Treatment Team

• Get Informed About Treatment

• Help Find the Right Treatment

• Get the Most from Treatment

• Counseling, Training, and Support

• Psychosocial Counseling

• Vocational Training

• Peer Support

• Understanding Relapse

• Care for the Caregiver

• Setting Realistic Goals Together

• Creating a Support System

• Developing Better Ways to Communicate

• Resource Center

• Useful Tools

• Calendar

• Refill Reminder

• Body Mass Index (BMI) Calculator

For healthcare professionals:

• ABILIFY.com Home Page for Healthcare Professionals

• Efficacy in Bipolar I Disorder

• Efficacy in Schizophrenia

• Safety

• Impact on Sedation

• Impact on Weight

• Metabolic Parameters

• Cardiovascular Parameters

• Other Parameters

• Unique Pharmacology

• Dosing Options

• Managing Expectations

• IMPORTANT SAFETY INFORMATION

• FULL PRESCRIBING INFORMATION including Boxed WARNING

• About Bipolar Disorder

• Diagnostic Criteria

• Mood Disorder Questionnaire

• Epidemiology

• Pathophysiology

• Young Mania Rating Scale

• Clinical Global Impression-Bipolar Scale

• About Schizophrenia

• Diagnostic Criteria

• Epidemiology

• Pathophysiology

• Positive and Negative Syndrome Scale (PANSS™)

Before you start treatment with ABILIFY, you should read the IMPORTANT SAFETY INFORMATION below.

IMPORTANT SAFETY INFORMATION and INDICATION for ABILIFY^® (aripiprazole)

INDICATION: ABILIFY (aripiprazole) is indicated for the treatment of:

Schizophrenia, including maintaining stability in patients who had been symptomatically stable on other antipsychotic medications for periods of 3 months or longer and observed for relapse during a period of up to 26 weeks

IMPORTANT SAFETY INFORMATION: Elderly patients, diagnosed with psychosis as a result of dementia (for example, an inability to perform daily activities as a result of increased memory loss), and who are treated with atypical antipsychotic medicines including ABILIFY, are at an increased risk of death when compared to patients who are treated with a placebo (sugar pill). ABILIFY is not approved for the treatment of patients with dementia-related psychosis.

Serious side effects can occur with any antipsychotic medicine, including ABILIFY. Tell your healthcare professional right away if you have any conditions or side effects, including the following:

Very high fever, rigid muscles, shaking, confusion, sweating, or increased heart rate and blood pressure. These may be signs of a condition called neuroleptic malignant syndrome (NMS), a rare but serious side effect which could be fatal

Abnormal or uncontrollable movements. These may be signs of a serious condition called tardive dyskinesia, which may be permanent
Elderly: An increased risk of stroke and ministroke has been reported in a clinical study of elderly patients with dementia-related psychosis
Diabetes, risk factors for diabetes (for example, obesity, family history of diabetes), or unexpected increases in thirst, urination, or hunger. Increases in blood sugar levels (hyperglycemia), in some cases serious and associated with coma or death, have been reported in patients taking medicines like ABILIFY. Ask your healthcare professional about the need to monitor your blood sugar level before and during treatment

Lightheadedness or faintness caused by a sudden change in heart rate and blood pressure when rising quickly from a sitting or lying position (orthostatic hypotension) has been reported with ABILIFY. Medicines like ABILIFY can affect your judgment, thinking, or motor skills. You should not drive or operate hazardous machinery until you know how ABILIFY affects you.

Since medicines like ABILIFY can impact your body�s ability to reduce body temperature, you should avoid overheating and dehydration.

Medicines like ABILIFY have been associated with swallowing problems (dysphagia). If you had or have swallowing problems, you should tell your healthcare professional.

If you have suicidal thoughts, you should tell your healthcare professional right away.

While taking ABILIFY, avoid:

Drinking alcohol

Breast-feeding an infant

Tell your healthcare professional if you have a history of seizures, or are pregnant or intend to become pregnant, and about all prescription and non-prescription medicines you are taking or plan to take.

Other common side effects include: headache, anxiety, insomnia, nausea, vomiting, constipation, dizziness, upset stomach, and an inner sense of restlessness or need to move (akathisia).

For patients who must limit their sugar intake, ABILIFY Oral Solution contains sugar.

For patients who cannot metabolize phenylalanine (those with phenylketonuria or PKU), ABILIFY^® DISCMELT� (aripiprazole) contains phenylalanine.

If you have any questions about your health or medicines, talk to your healthcare professional.

Please see IMPORTANT SAFETY INFORMATION and FULL PRODUCT INFORMATION including Boxed WARNING for ABILIFY (aripiprazole).